« Previous
Next »
Titles
- FDA deems certain tobacco products subject to FDA authority, sales and distribution restrictions, and health warning requirements for packages and advertisements: (revised)1
- FDA oversight1
- Facility quality and safety1
- Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications: guidance for industry and Food and Drug Administration staff1
- Federal Medicaid policy1
- Federal mandatory spending for means-tested programs: 2009 to 20291
- Federalism, the Affordable Care Act, and health reform in the 2020 election1
- Financial performance of Medicare Advantage, individual, and group health insurance markets1
- Food labeling: serving sizes of foods that can reasonably be consumed at one eating occasion, reference amounts customarily consumed, serving size-related issues, dual-column labeling, and miscellaneous topics1
- Forecasting the future: new 'Paradigm Project' focuses on rethinking health services research1
- Four methods for calculating income as a percent of the federal poverty guideline (FPG) in the Behavioral Risk Factor Surveillance System (BRFSS)1
- From ballot initiative to waivers: what is the status of Medicaid expansion in Utah?2
- Funding and insurance1
- Further testing of donations that are reactive on a licensed donor screening test for antibodies to hepatitis C virus1